Webinar: Focus on Understanding Clinical Trials and How to Identify the Right One for You

January 22, 2022

with Andrew M. Brunner, MD, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School

MDS patients should consider clinical trials as a viable route for treatment, not just a last resort. Attend this event to learn about innovative treatments for AML and MDS that are being evaluated in trials, the latest research from the American Society of Hematology, and how to choose the right clinical trial.

To register, click here.